Skip to main content
OpenTrials
Completed

NCT Number: NCT05995561

HERA FIb Registry for Patients With Atrial Fibrillation

The single-center HERA AFIb registry was created to assess real-world prevalence, demographic characteristics and management of patients with atrial fibrillation (AF) in the era of novel oral anticoagulant regimes (NOAC) presenting in the emergency department (ED) of University of Heidelberg

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital of Heidelberg

Heidelberg, Baden-Wurttemberg, 69120, Germany

About this study

HERA AFIb is a single-center retrospective registry which enrolled consecutive cases presenting with atrial fibrillation at the emergency department of University Hospital of Heidelberg. Clinical parameters and characteristics for cases were assessed retrospectively. Follow-up was performed via review of medical reports, phone calls and postal queries. Outcome parameters included rates for all-cause mortality, non-hemorrhagic stroke, myocardial infarction and major bleeding.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • documented atrial fibrillation
  • availability of at least one hsTnT measurement

Exclusion criteria

  • lost to follow-up

Treatment and study plan

no intervention is planned.

Other

no intervention is planned.

Primary outcomes

  1. all-cause mortality

    Time frame: 24 months

    all-cause mortality during follow-up

Secondary outcomes

  1. ischaemic stroke

    Time frame: 24 months

    ischaemic stroke during follow-up

  2. major bleeding

    Time frame: 24 months

    major bleeding during follow-up

  3. myocardial infarction

    Time frame: 24 months

    myocardial infarction during follow-up

Sponsors and collaborators

Lead sponsor

University Hospital Heidelberg

Other

Registry information

Official study title

Heidelberg Registry of Atrial Fibrillation

Important dates

Study start
2009
Primary completion
2020
Study completion
2020
First posted
Aug 16, 2023
Registry last updated
May 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.